Exane Asset Management Amgen Inc Transaction History

Exane Asset Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $455,359 - $530,647	-2,052 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $318,944 - $379,805	-1,474 Reduced 41.8%	2,052 $471,000
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $3.88 Million - $4.98 Million	-20,482 Reduced 85.31%	3,526 $850,000
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $4.18 Million - $5.01 Million	24,008 New	24,008 $4.65 Million

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.